This article is more than 5 years old. Information may no longer be current.
Wright Medical Group, Inc. announces limited release of hammertoe fixation system
Click Here to Manage Email Alerts
Wright Medical Group, Inc. announced the limited release of the PRO-TOE VO Hammertoe Fixation System. This new product introduction is an important solution for patients requiring fusion of the lesser toes for hammertoe deformities, the company noted in a press release.
A hammertoe is a deformity of the tissues surrounding the bony structures of the lesser toes. The patient’s toes elevate and cause discomfort while wearing shoes. Designed by world-renowned foot and ankle surgeons, the PRO-TOE VO Hammertoe system is an efficient surgical solution for fixation of the bones being corrected, according to the press release.
Robert B. Anderson, MD, of OrthoCarolina in Charlotte, North Carolina stated, “The PRO-TOE VO Hammertoe system provides a simple and economical solution for my patients with hammertoe deformities. The system offers solid fixation on both sides of the joint and the unique geometry allows for it to be precisely repositioned during surgery to provide the best clinical outcomes for the patient.” Anderson and his partners will be reviewing their early clinical experience with the PRO-TOE™ VO implant at Wright’s upcoming “Advances in Foot and Ankle Surgery” symposium on December 10th in New York City.
“Hammertoes are a significant problem for individuals around the globe,” stated Bob Fencl, director of Foot & Ankle Marketing for Wright. “In the United States alone, it is estimated that 10% to 20% of the population suffers from hammertoes with over 500,000 patients requiring surgical treatment each year. The PRO-TOE VO Hammertoe implant provides patients, surgeons and facilities distinct advantages over conventional treatment methods available today.”
The new PRO-TOE VO Hammertoe System will be made available in a limited-release immediately in the United States through Wright’s specialized Foot and Ankle sales force. Full rollout is expected to be completed by the first half of 2011. Additionally, the system will be marketed in select countries outside the United States through Wright’s direct and distributor-based sales representatives.
- Robert B. Anderson, MD is a paid consultant for Wright Medical Technology and receives research support as a principal investigator and royalties from the company.